跳至主要内容
临床试验/NCT02432599
NCT02432599已完成2 期

Interest of the F18-choline as a Second Line of the Tracer for Detection of Parathyroid Adenomas

Centre Francois Baclesse4 个研究点 分布在 1 个国家目标入组 28 人开始时间: 2015年3月1日最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
28
试验地点
4
主要终点
Sensitivity (ability to identify and visualize the parathyroid adenoma)

研究概览

简要总结

The rationale for the proposed pilot study is to investigate the ability of PET-CT with F18-choline to detect and locate the parathyroid adenoma in patients with primary hyperparathyroidism and negative or non-contributory MIBI (Tc-99m sestamibi) and cervical ultrasound, in order to avoid unnecessary bilateral cervical exploration.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Diagnostic
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patient aged 18 years or more;
  • Patient with a primary hyperparathyroidism and witj a negative or non-contriburatory MIBI parathyroid scintigraphy and neck ultrasonography, for which surgical resection is planned;
  • Confirmation of the diagnosis of primary hyperparathyroidism on laboratory tests
  • Affiliate to a social security system;
  • Patient written informed consent.

排除标准

  • Patient deprived of liberty, under guardianship;
  • Any medical or psychological condition witch could compromise the capacity of the patient to participate in the study;
  • Pregnant or breastfeeding

结局指标

主要结局

Sensitivity (ability to identify and visualize the parathyroid adenoma)

时间窗: Up to 2 months

Sensitivity of PET-CT with F18-choline (FCH) to identify and visualize the parathyroid adenoma in patients with primary hyperparathyroidism and negative or non-contributory parathyroid scintigraphy MIBI and cervical ultrasound

次要结局

未报告次要终点

研究者

发起方
Centre Francois Baclesse
申办方类型
Other
责任方
Sponsor

研究点 (4)

Loading locations...

相似试验

Interest of the F18-choline as a Second Line of the... | 临床试验